<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Fatty acid metabolism is altered in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We aimed to investigate incorporation of dietary n-6 and n-3 polyunsaturated fatty acids (PUFAs) into plasma <z:chebi fb="1" ids="16247">phospholipids</z:chebi> (PLs), <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissue, and <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa in young <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
<SENT sid="2" pm="."><plain>We also aimed to study differences in PUFA composition between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa, and PUFA status associated with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stage </plain></SENT>
<SENT sid="3" pm="."><plain>Sixty-five <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients younger than 55 years were included in a multicenter study </plain></SENT>
<SENT sid="4" pm="."><plain>We assessed dietary fatty acid composition by food-frequency questionnaire </plain></SENT>
<SENT sid="5" pm="."><plain>Fatty acid composition in plasma PL (n = 65) and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> colonic biopsies (n = 32) were analysed by gas chromatography </plain></SENT>
<SENT sid="6" pm="."><plain>We observed a significant correlation for <z:chebi fb="0" ids="36005">docosahexaenoic acid</z:chebi> (DHA) between dietary intake and concentration in plasma PL (weight%) (r = 0.42; P = 0.001), but not for any n-6 PUFA </plain></SENT>
<SENT sid="7" pm="."><plain>Tissue concentrations of <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi>, eicosapentaenoic acid, and DHA (weight%) were 1.7-2.5 times higher in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> than <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa (P â‰¤ 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>Concentrations of n-3 and n-6 PUFA in plasma PL and tissues were not related to Duke's stage, although patients with more severe <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stage reported higher intake of n-3 PUFA </plain></SENT>
<SENT sid="9" pm="."><plain>In conclusion, we found accumulation of the long-chained n-3 and n-6 PUFA in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissue in young <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients </plain></SENT>
</text></document>